Literature DB >> 10400731

Proteolytic activity, the carboxy terminus of Gag, and the primer binding site are not required for Pol incorporation into foamy virus particles.

D N Baldwin1, M L Linial.   

Abstract

Human foamy virus (HFV) is the prototype member of the spumaviruses. While similar in genomic organization to other complex retroviruses, foamy viruses share several features with their more distant relatives, the hepadnaviruses such as human hepatitis B virus (HBV). Both HFV and HBV express their Pol proteins independently from the structural proteins. However unlike HBV, Pol is not required for assembly of HFV core particles or for packaging of viral RNA. These results suggest that the assembly of Pol into HFV particles must occur by a mechanism different from those used by retroviruses and hepadnaviruses. We have examined possible mechanisms for HFV Pol incorporation, including the role of proteolysis in assembly of Pol and the role of initiation of reverse transcription. We have found that proteolytic activity is not required for Pol incorporation. p4 Gag and the residues immediately upstream of the cleavage site in Gag are also not important. Deletion of the primer binding site had no effect on assembly, ruling out early steps of reverse transcription in the process of Pol incorporation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400731      PMCID: PMC112718     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly.

Authors:  R C Craven; R P Bennett; J W Wills
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

2.  Novel mechanism for reverse transcription in hepatitis B viruses.

Authors:  G H Wang; C Seeger
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

3.  The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation.

Authors:  R Bartenschlager; M Junker-Niepmann; H Schaller
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

4.  trans-acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase.

Authors:  L Stewart; V M Vogt
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.

Authors:  V Karacostas; E J Wolffe; K Nagashima; M A Gonda; B Moss
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

6.  An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation.

Authors:  J R Pollack; D Ganem
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  Expression of the P-protein of the human hepatitis B virus in a vaccinia virus system and detection of the nucleocapsid-associated P-gene product by radiolabelling at newly introduced phosphorylation sites.

Authors:  R Bartenschlager; C Kuhn; H Schaller
Journal:  Nucleic Acids Res       Date:  1992-01-25       Impact factor: 16.971

8.  Molecular cloning of the genome of human spumaretrovirus.

Authors:  A Rethwilm; G Darai; A Rösen; B Maurer; R M Flügel
Journal:  Gene       Date:  1987       Impact factor: 3.688

9.  Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome.

Authors:  R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

Review 10.  Translational suppression in retroviral gene expression.

Authors:  D L Hatfield; J G Levin; A Rein; S Oroszlan
Journal:  Adv Virus Res       Date:  1992       Impact factor: 9.937

View more
  17 in total

1.  Complex effects of deletions in the 5' untranslated region of primate foamy virus on viral gene expression and RNA packaging.

Authors:  M Heinkelein; J Thurow; M Dressler; H Imrich; D Neumann-Haefelin; M O McClure; A Rethwilm
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Foamy virus Pol protein expressed as a Gag-Pol fusion retains enzymatic activities, allowing for infectious virus production.

Authors:  Eun-Gyung Lee; Amber Sinicrope; Dana L Jackson; Shuyuarn F Yu; Maxine L Linial
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

3.  RNA and protein requirements for incorporation of the Pol protein into foamy virus particles.

Authors:  Katrin Peters; Tatiana Wiktorowicz; Martin Heinkelein; Axel Rethwilm
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Protease-dependent uncoating of a complex retrovirus.

Authors:  Jacqueline Lehmann-Che; Marie-Lou Giron; Olivier Delelis; Martin Löchelt; Patricia Bittoun; Joelle Tobaly-Tapiero; Hugues de Thé; Ali Saïb
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly.

Authors:  S W Eastman; M L Linial
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Using hyperLOPIT to perform high-resolution mapping of the spatial proteome.

Authors:  Claire M Mulvey; Lisa M Breckels; Aikaterini Geladaki; Nina Kočevar Britovšek; Daniel J H Nightingale; Andy Christoforou; Mohamed Elzek; Michael J Deery; Laurent Gatto; Kathryn S Lilley
Journal:  Nat Protoc       Date:  2017-05-04       Impact factor: 13.491

7.  Foamy virus Gag p71-p68 cleavage is required for template switch of the reverse transcriptase.

Authors:  Ralf Spannaus; Anna Schneider; Maximilian J Hartl; Birgitta M Wöhrl; Jochen Bodem
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

8.  Cell-type-specific regulation of the two foamy virus promoters.

Authors:  C D Meiering; C Rubio; C May; M L Linial
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

9.  Pregenomic RNA is required for efficient incorporation of pol polyprotein into foamy virus capsids.

Authors:  Martin Heinkelein; Cordula Leurs; Matthias Rammling; Katrin Peters; Helmut Hanenberg; Axel Rethwilm
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Mutation of the catalytic domain of the foamy virus reverse transcriptase leads to loss of processivity and infectivity.

Authors:  Carolyn S Rinke; Paul L Boyer; Mark D Sullivan; Stephen H Hughes; Maxine L Linial
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.